首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131
【2h】

A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131

机译:一个新的克隆清除干净:大肠杆菌序列类型131的神秘出现。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Escherichia coli sequence type 131 (ST131) is an extensively antimicrobial-resistant E. coli clonal group that has spread explosively throughout the world. Recent molecular epidemiologic and whole-genome phylogenetic studies have elucidated the fine clonal structure of ST131, which comprises multiple ST131 subclones with distinctive resistance profiles, including the (nested) H30, H30-R, and H30-Rx subclones. The most prevalent ST131 subclone, H30, arose from a single common fluoroquinolone (FQ)-susceptible ancestor containing allele 30 of fimH (type 1 fimbrial adhesin gene). An early H30 subclone member acquired FQ resistance and launched the rapid expansion of the resulting FQ-resistant subclone, H30-R. Subsequently, a member of H30-R acquired the CTX-M-15 extended-spectrum beta-lactamase and launched the rapid expansion of the CTX-M-15-containing subclone within H30-R, H30-Rx. Clonal expansion clearly is now the dominant mechanism for the rising prevalence of both FQ resistance and CTX-M-15 production in ST131 and in E. coli generally. Reasons for the successful dissemination and expansion of the key ST131 subclones remain undefined but may include increased transmissibility, greater ability to colonize and/or persist in the intestine or urinary tract, enhanced virulence, and more-extensive antimicrobial resistance compared to other E. coli. Here we discuss the epidemiology and molecular phylogeny of ST131 and its key subclones, possible mechanisms for their ecological success, implications of their widespread dissemination, and future research needs.
机译:大肠杆菌131型序列(ST131)是一种广泛耐药的大肠杆菌克隆群,已在全球范围内爆发性扩散。最近的分子流行病学和全基因组系统发育研究阐明了ST131的精细克隆结构,该结构包含多个具有不同抗性的ST131亚克隆,包括(嵌套的)H30,H30-R和H30-Rx亚克隆。最普遍的ST131亚克隆H30来自单个常见的氟喹诺酮(FQ)敏感祖先,该祖先包含fimH(1型纤维粘附素基因)等位基因30。 H30的早期亚克隆成员获得了FQ抗性,并迅速扩展了所得的抗FQ的亚克隆H30-R。随后,H30-R的成员获得了CTX-M-15广谱β-内酰胺酶,并启动了H30-R,H30-Rx中含CTX-M-15的亚克隆的快速扩增。现在,克隆扩增显然是导致ST131和一般大肠杆菌中FQ抗性和CTX-M-15产生率增加的主要机制。与其他大肠杆菌相比,成功传播和扩展关键ST131亚克隆的原因尚不确定,但可能包括增加的可传播性,在肠道或尿道中定植和/或持久存在的能力,增强的毒力以及更广泛的抗药性。在这里,我们讨论ST131及其关键亚克隆的流行病学和分子系统发育,其生态学成功的可能机制,其广泛传播的意义以及未来的研究需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号